Ignite Creation Date:
2025-12-26 @ 10:56 AM
Ignite Modification Date:
2026-03-03 @ 8:11 AM
Study NCT ID:
NCT02406508
Status:
WITHDRAWN
Last Update Posted:
2017-12-18
First Post:
2015-03-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC
Sponsor:
Delcath Systems Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PHP-HCC-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None